Gene · 1763
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling. | Nat Commun | 2022 | 36085347 | PubTator, text mining | PubMed |
| Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks. | Nat Commun | 2022 | 36075911 | PubTator, text mining | PubMed |
| MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner. | Nat Commun | 2022 | 36075897 | PubTator, text mining | PubMed |
| Double-stranded DNA binding function of RAD51 in DNA protection and its regulation by BRCA2. | Mol Cell | 2022 | 36070766 | PubTator, text mining | PubMed |
| DNA2 mutation causing multisystemic disorder with impaired mitochondrial DNA maintenance. | J Hum Genet | 2022 | 36064591 | PubTator, text mining | PubMed |
| A multi-functional role for the MCM8/9 helicase complex in maintaining fork integrity during replication stress. | Nat Commun | 2022 | 36042199 | PubTator, text mining | PubMed |
| Different classes of genomic inserts contribute to human antibody diversity. | Proc Natl Acad Sci U S A | 2022 | 36037353 | PubTator, text mining | PubMed |
| Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies. | Front Mol Biosci | 2022 | 36032672 | PubTator, text mining | PubMed |
| The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1. | Nat Commun | 2022 | 36030235 | PubTator, text mining | PubMed |
| Noncanonical DNA Cleavage by BamHI Endonuclease in Laterally Confined DNA Monolayers Is a Step Function of DNA Density and Sequence. | Molecules | 2022 | 36014501 | PubTator, text mining | PubMed |
| Increased Gene Targeting in Hyper-Recombinogenic LymphoBlastoid Cell Lines Leaves Unchanged DSB Processing by Homologous Recombination. | Int J Mol Sci | 2022 | 36012445 | PubTator, text mining | PubMed |
| The Ubiquitin Ligase RNF138 Cooperates with CtIP to Stimulate Resection of Complex DNA Double-Strand Breaks in Human G1-Phase Cells. | Cells | 2022 | 36010636 | PubTator, text mining | PubMed |
| Development of an Automatable Affinity Purification Process for DNA-Encoded Chemistry. | ACS Omega | 2022 | 35990424 | PubTator, text mining | PubMed |
| A synthetic biology approach reveals diverse and dynamic CDK response profiles via multisite phosphorylation of NLS-NES modules. | Sci Adv | 2022 | 35977012 | PubTator, text mining | PubMed |
| DNA double-strand break repair and nucleic acid-related immunity. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35975605 | PubTator, text mining | PubMed |
| Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems. | Bioimpacts | 2022 | 35975201 | PubTator, text mining | PubMed |
| RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress. | PLoS One | 2022 | 35969531 | PubTator, text mining | PubMed |
| A CRISPR-Cas12a integrated SERS nanoplatform with chimeric DNA/RNA hairpin guide for ultrasensitive nucleic acid detection. | Theranostics | 2022 | 35966585 | PubTator, text mining | PubMed |
| RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors. | J Biol Chem | 2022 | 35952757 | PubTator, text mining | PubMed |
| Replication dependent and independent mechanisms of GAA repeat instability. | DNA Repair (Amst) | 2022 | 35952488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1763/papers?page=17